Market Cap 157.99B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.09
Forward PE 9.31
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 40,435,800
Avg Vol 37,089,902
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 16%
Beta 0.34
Analysts Sell
Price Target $28.92

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
My_Lai_1968
My_Lai_1968 Sep. 16 at 5:47 AM
$PFE My ex-girlfriend recently took her Aunt's very young step-daughter to the Emergency room when the child suddenly developed a blotchy, bumpy skin infection. The infection did not hurt at all but it was very visible. The doctor there gave the little girl one of Pfizer's medications in an injection in her upper arm, slightly above the elbow yet still below the tricep area. As the needle pricked the skin, my ex-girlfriend said the child repeatedly said, "ouchey oochie, ouchie oochey" and then began giggling. The doctor and the nurse in the room both stated that this reaction was the first time they'd ever heard such a thing.The injection brought down the red blotches significantly in about one hour. More people should bring their children to the doctor if they have the same condition.
0 · Reply
PhantomZ
PhantomZ Sep. 16 at 12:13 AM
$MRK $PFE $RVMD $CGON $BMY many posssible combination with IV injected Rutherin when activated by X-rays increases Tumor cell kill 100 fold vs radiation therapy alone. newsfilecorp.com/release/31...
1 · Reply
focafoca99
focafoca99 Sep. 15 at 7:45 PM
$PFE released a webcast invitation to hear its discussion at the J.P. Morgan U.S. All Stars 2026 Conference on Sept 22. https://www.rapidticker.com/news/pfe-pfizer-invites-public-to-listen-95a936
0 · Reply
Steve_Lattimer
Steve_Lattimer Sep. 15 at 4:37 PM
$ADTX $NVDA $PFE $MRNA $UNH Chance of a lifetime. Invest in the future. Previous price target was $62.00 before getting delisted. Plenty of catalysts still there including a $150 million SPAC merger.
0 · Reply
stockjusthave
stockjusthave Sep. 15 at 4:22 PM
$PFE seeing people saying over priced here, i say its 100 percent undervalued when compared to the peers. people saying over priced wanted some cheapies that's all. If not willing to buy in at 27 will buy at 40 or more
0 · Reply
jrh34
jrh34 Sep. 15 at 4:21 PM
$CRDF I said $2 was done deal. I just don’t know what happens after that. Could be sideways or we could get an acquisition offer from $PFE I always thought Erlander’s early departure was related to his dual trigger change in control clause.
0 · Reply
simonds
simonds Sep. 15 at 4:15 PM
$PFE This is way over priced, especially with interest rates rising and pipeline plugged up.
0 · Reply
INEEDMONEY87
INEEDMONEY87 Sep. 15 at 2:42 PM
$PFE o i cut it over this red show
0 · Reply
truthseeeker
truthseeeker Sep. 15 at 2:21 PM
$PFE The correction which is taking place in PFE shares was INEVITABLE as a price of $29 was and continues to be ridiculously overpriced. At $27, PFE is fairly valued , not undervalued or overvalued.
1 · Reply
INEEDMONEY87
INEEDMONEY87 Sep. 15 at 1:31 PM
$PFE wtf
0 · Reply
Latest News on PFE
Pfizer price target raised to $30 from $28 at HSBC

2026-09-10T10:25:13.000Z - 5 days ago

Pfizer price target raised to $30 from $28 at HSBC


Trump administration to announce drug pricing deals

Aug 31, 2026, 12:09 PM EDT - 15 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK


Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-24T12:18:00.000Z - 22 days ago

Pfizer Stock (PFE) Is a Buy despite Declining Revenue


Pfizer, Valneva announce EMA validation for PF-07307405 MAA

2026-08-16T13:55:21.000Z - 4 weeks ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 6 weeks ago

Pfizer Post Loss on Higher Revenue


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 2 months ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 3 months ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Press release: Study update


Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026


My_Lai_1968
My_Lai_1968 Sep. 16 at 5:47 AM
$PFE My ex-girlfriend recently took her Aunt's very young step-daughter to the Emergency room when the child suddenly developed a blotchy, bumpy skin infection. The infection did not hurt at all but it was very visible. The doctor there gave the little girl one of Pfizer's medications in an injection in her upper arm, slightly above the elbow yet still below the tricep area. As the needle pricked the skin, my ex-girlfriend said the child repeatedly said, "ouchey oochie, ouchie oochey" and then began giggling. The doctor and the nurse in the room both stated that this reaction was the first time they'd ever heard such a thing.The injection brought down the red blotches significantly in about one hour. More people should bring their children to the doctor if they have the same condition.
0 · Reply
PhantomZ
PhantomZ Sep. 16 at 12:13 AM
$MRK $PFE $RVMD $CGON $BMY many posssible combination with IV injected Rutherin when activated by X-rays increases Tumor cell kill 100 fold vs radiation therapy alone. newsfilecorp.com/release/31...
1 · Reply
focafoca99
focafoca99 Sep. 15 at 7:45 PM
$PFE released a webcast invitation to hear its discussion at the J.P. Morgan U.S. All Stars 2026 Conference on Sept 22. https://www.rapidticker.com/news/pfe-pfizer-invites-public-to-listen-95a936
0 · Reply
Steve_Lattimer
Steve_Lattimer Sep. 15 at 4:37 PM
$ADTX $NVDA $PFE $MRNA $UNH Chance of a lifetime. Invest in the future. Previous price target was $62.00 before getting delisted. Plenty of catalysts still there including a $150 million SPAC merger.
0 · Reply
stockjusthave
stockjusthave Sep. 15 at 4:22 PM
$PFE seeing people saying over priced here, i say its 100 percent undervalued when compared to the peers. people saying over priced wanted some cheapies that's all. If not willing to buy in at 27 will buy at 40 or more
0 · Reply
jrh34
jrh34 Sep. 15 at 4:21 PM
$CRDF I said $2 was done deal. I just don’t know what happens after that. Could be sideways or we could get an acquisition offer from $PFE I always thought Erlander’s early departure was related to his dual trigger change in control clause.
0 · Reply
simonds
simonds Sep. 15 at 4:15 PM
$PFE This is way over priced, especially with interest rates rising and pipeline plugged up.
0 · Reply
INEEDMONEY87
INEEDMONEY87 Sep. 15 at 2:42 PM
$PFE o i cut it over this red show
0 · Reply
truthseeeker
truthseeeker Sep. 15 at 2:21 PM
$PFE The correction which is taking place in PFE shares was INEVITABLE as a price of $29 was and continues to be ridiculously overpriced. At $27, PFE is fairly valued , not undervalued or overvalued.
1 · Reply
INEEDMONEY87
INEEDMONEY87 Sep. 15 at 1:31 PM
$PFE wtf
0 · Reply
DaveOOOOOH
DaveOOOOOH Sep. 15 at 1:00 PM
$PFE I wish this corrupt company would go bankrupt. Not enough people do, especially those with the power to expose them, so I don't think it will ever happen.
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 15 at 6:03 AM
Can Viking Therapeutics Beat Big Pharma With Monthly Weight-Loss Shots? Here’s The Risk CEO Says Could Derail It $VKTX $NVO $LLY $PFE https://stocktwits.com/news/equity/markets/viking-therapeutics-big-pharma-monthly-weight-loss-shots-risk-ceo-derail/cZtnGIiRBTV
0 · Reply
jrh34
jrh34 Sep. 15 at 3:56 AM
$CRDF mPFS is up next, followed by an offer from $PFE for $1.2 Billion, which Cardiff will accept - it's a done deal. Pace isn't going to let them go it alone and chase a P3, that's never successful. Sell it at a discount is what will happen. Glad to see today's settlement. I will be adding more shares tomorrow.
3 · Reply
simonds
simonds Sep. 15 at 3:18 AM
$PFE they suck
0 · Reply
SuperGreenToday
SuperGreenToday Sep. 15 at 3:01 AM
$PFE Share Price: $27.74 Contract Selected: Oct 09, 2026 $30 Calls Buy Zone: $0.03 – $0.03 Target Zone: $0.05 – $0.06 Potential Upside: 79% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jrh34
jrh34 Sep. 15 at 2:10 AM
$CRDF Is an $SLS type move or acquisition by $PFE to much to ask?
1 · Reply
smartfellar
smartfellar Sep. 14 at 9:59 PM
$PFE they will keep this below $28 all week so that my 1000s of calls expire worthless, sorry team
0 · Reply
JackedNicholson
JackedNicholson Sep. 14 at 9:30 PM
2 · Reply
edlu77
edlu77 Sep. 14 at 7:46 PM
$PFE Well today was embarrassing
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 14 at 6:21 PM
$SLS $JNJ$AZN $PFE Only☝️ Thing that requires this kind of 🤐 at this point is an outright BO! ✌️🙏❤️‍🩹
1 · Reply
taxplanr
taxplanr Sep. 14 at 5:35 PM
The zionist's were covering up COVID vaccines deaths also $MRNA $PFE $BNTX https://www.instagram.com/reel/DdReFG2xP_B/?stkn=ZmRlMnU4bGRwb2gz
4 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Sep. 14 at 2:56 PM
0 · Reply